1419 related articles for article (PubMed ID: 22503168)
1. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
2. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
3. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study.
Blumenstein I; Bock H; Weber C; Rambow A; Tacke W; Kihn R; Pfaff R; Orlemann S; Schaeffer R; Schröder O; Dignass A; Hartmann F; Stein J
Inflamm Bowel Dis; 2008 Jan; 14(1):53-60. PubMed ID: 17973301
[TBL] [Abstract][Full Text] [Related]
4. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Blumenstein I; Herrmann E; Filmann N; Zosel C; Tacke W; Bock H; Dignass A; Hartmann F; Zeuzem S; Stein J; Schröder O
J Crohns Colitis; 2011 Jun; 5(3):203-10. PubMed ID: 21575882
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
7. Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A; Bokemeyer B; von der Schulenburg JM; Mittendorf T
Eur J Health Econ; 2011 Jun; 12(3):273-83. PubMed ID: 20967482
[TBL] [Abstract][Full Text] [Related]
8. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
9. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany.
Wilke T; Groth A; Long GH; Tatro AR; Sun D
Clin Ther; 2020 Jan; 42(1):130-143.e3. PubMed ID: 31883702
[TBL] [Abstract][Full Text] [Related]
10. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
[TBL] [Abstract][Full Text] [Related]
11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
13. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Lakatos L; Lakatos PL
Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
[TBL] [Abstract][Full Text] [Related]
14. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment.
Casellas F; Robles V; Borruel N; Torrejón A; Castells I; Navarro E; Guarner F
J Crohns Colitis; 2012 Oct; 6(9):881-6. PubMed ID: 22398074
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis.
Odes S; Vardi H; Friger M; Esser D; Wolters F; Moum B; Waters H; Elkjaer M; Bernklev T; Tsianos E; O'Morain C; Stockbrügger R; Munkholm P; Langholz E
Aliment Pharmacol Ther; 2010 Apr; 31(7):735-44. PubMed ID: 20047578
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
17. Non-drug costs associated with outpatient infliximab administration in pediatric inflammatory bowel disease.
Wu M; Sin A; Nishioka F; Park KT
Inflamm Bowel Dis; 2013 Jun; 19(7):1514-7. PubMed ID: 23567783
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
19. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.
Horst S; Chao A; Rosen M; Nohl A; Duley C; Wagnon JH; Beaulieu DB; Taylor W; Gaines L; Schwartz DA
Dig Dis Sci; 2015 Feb; 60(2):465-70. PubMed ID: 25274158
[TBL] [Abstract][Full Text] [Related]
20. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
